We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
Read MoreHide Full Article
In the latest trading session, Intuitive Surgical, Inc. (ISRG - Free Report) closed at $334.94, marking a +1.48% move from the previous day. This change outpaced the S&P 500's 0.41% gain on the day.
Prior to today's trading, shares of the company had lost 8.16% over the past month. This has was narrower than the Medical sector's loss of 9.69% and lagged the S&P 500's loss of 4.08% in that time.
Wall Street will be looking for positivity from ISRG as it approaches its next earnings report date. This is expected to be October 19, 2021. In that report, analysts expect ISRG to post earnings of $1.19 per share. This would mark a year-over-year decline of 57.04%. Our most recent consensus estimate is calling for quarterly revenue of $1.39 billion, up 29.28% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.93 per share and revenue of $5.65 billion, which would represent changes of -51.48% and +29.55%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for ISRG. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.68% lower. ISRG is holding a Zacks Rank of #3 (Hold) right now.
In terms of valuation, ISRG is currently trading at a Forward P/E ratio of 66.98. This valuation marks a premium compared to its industry's average Forward P/E of 46.13.
We can also see that ISRG currently has a PEG ratio of 7.05. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. ISRG's industry had an average PEG ratio of 3.06 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 159, which puts it in the bottom 38% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Intuitive Surgical, Inc. (ISRG) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Intuitive Surgical, Inc. (ISRG - Free Report) closed at $334.94, marking a +1.48% move from the previous day. This change outpaced the S&P 500's 0.41% gain on the day.
Prior to today's trading, shares of the company had lost 8.16% over the past month. This has was narrower than the Medical sector's loss of 9.69% and lagged the S&P 500's loss of 4.08% in that time.
Wall Street will be looking for positivity from ISRG as it approaches its next earnings report date. This is expected to be October 19, 2021. In that report, analysts expect ISRG to post earnings of $1.19 per share. This would mark a year-over-year decline of 57.04%. Our most recent consensus estimate is calling for quarterly revenue of $1.39 billion, up 29.28% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $4.93 per share and revenue of $5.65 billion, which would represent changes of -51.48% and +29.55%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for ISRG. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 3.68% lower. ISRG is holding a Zacks Rank of #3 (Hold) right now.
In terms of valuation, ISRG is currently trading at a Forward P/E ratio of 66.98. This valuation marks a premium compared to its industry's average Forward P/E of 46.13.
We can also see that ISRG currently has a PEG ratio of 7.05. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. ISRG's industry had an average PEG ratio of 3.06 as of yesterday's close.
The Medical - Instruments industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 159, which puts it in the bottom 38% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.